Dr. Spelman interviews Donald Abrams, MD on his extensive experience working with cannabinoids in cancer patients. The newest research in this episode explores the application of Shitake mushroom in hypercholesterolemia.

Dr. Spelman covers new research on Sambucus ebulus as a topical treatment for eczema, examines Big Pharma’s reaction to pleiotropy, and continues his discussion with David Hoffmann.

Dr. Spelman covers new research on glycyrrhizin’s antiviral effects, discusses dosing in botanical medicine, and speaks with naturopathic physician Dr. Michaël Friedman.

Dr. Spelman reviews new data on selenium and COVID and discusses cannabinoid efficacy as an adjuvant treatment in cancer, including an interview with Dr. Jeff Hergenrather on cannabinoid use by cancer patients.